Pain: Screen and Treat

Royal Marsden NHS Foundation Trust156 enrolled

Overview

This study is looking at treating cancer pain in head and neck cancer. Patients are asked in outpatients to score their worst pain on a scale of 0 to 10 in the last 24 hours. Those with a pain score of 4 and above are randomised into the study. Patients are allocated to continue with their current care (control group) or to be reviewed by the pain/palliative care team (intervention group). At baseline questionnaires are completed on level of pain, type of pain, quality of life and anxiety/depression. Information is also collected on the analgesia they've used in the past month and basic health economics (GP/hospital visits related to pain management and treatment). Follow up in the trial is for 3 months and consists of questionnaires as above and further collection of information on analgesic usage and health economics.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

156

Conditions

Head and Neck Cancer Pain

Interventions

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients attending head and neck oncology clinics * Patients with a cancer diagnosis who are receiving anti cancer treatment or who have received anti cancer treatment * Patients who score 4 or more on the Brief Pain Inventory numerical rating scale screening question 'worst pain in past 24 hours' Exclusion Criteria: * age below 18 years * patients unable to respond to an English written assessment * patients with medical conditions that could affect their mental function or level of consciousness such as stroke, or dementia * patients who score \<4 on the Brief Pain Inventory numerical rating scale screening question * patients already under the care of a pain/palliative care service

Outcomes

Primary Outcomes

The change in pain score summarized from patient reports

Time frame: 1 month, 2 months and 3 months

Secondary Outcomes

Impact of pain

Measured by the brief pain inventory questionnaire

Time frame: 1 month, 2 months, 3 months

Adequacy of pain treatment

Using Pain Management Index, calculated from BPI and WHO ladder

Time frame: 1 month, 2 months and 3 months

Quality of life

Assessed using the EQ-5D questionnaire

Time frame: 1 month, 2 months and 3 months

Patient satisfaction

Likert scale

Time frame: 1 month, 2 months and 3 months

Anxiety and depression

Assessed using the Hospital anxiety and depression questionnaire

Time frame: 1 month, 2 months and 3 months

Treatment costs

Information collected on analgesic usage and contact with healthcare professionals for pain management purposes

Time frame: 1 month, 2 months and 3 months

Pain: Screen and Treat

Overview

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Primary Outcomes

Secondary Outcomes